AKLIEF 50mcg/G cream medication leaflet

D10AD06 trifaroten • Dermatologicals | Anti-acne preparations for topical use | Retinoids for topical use in acne

Trifarotene is a fourth-generation retinoid used in the treatment of acne vulgaris and other dermatological conditions characterized by abnormal keratinization. It works by selectively binding to RAR-gamma receptors, which are involved in regulating cellular differentiation and proliferation in the skin.

Trifarotene is available as a topical cream and is applied directly to the affected skin, usually once daily in the evening. It is effective in reducing inflammatory and non-inflammatory acne lesions, as well as improving skin texture.

Common side effects include skin dryness, erythema, peeling, and a burning or stinging sensation at the application site. Patients are advised to use sunscreen, as trifarotene may increase skin sensitivity to UV radiation.

Trifarotene is an innovative therapeutic option for patients with acne, offering a favorable safety and efficacy profile with significant benefits for skin health.

General data about AKLIEF 50mcg/G

Substance: trifaroten

Date of last drug list: 01-06-2025

Commercial code: W68352004

Concentration: 50mcg / g

Pharmaceutical form: cream

Quantity: 1

Product type: original

Price: 176.51 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: GALDERMA LABORATORIUM GMBH - GERMANIA

Holder: GALDERMA INTERNATIONAL - FRANTA

Number: 14177/2021/04

Shelf life: 2 years-after packaging for sale;6 months-after the first opening of the tube sau flac.

Other substances similar to trifaroten